Efficacy and Safety of Apixaban in Patients Following Cardioversion for Atrial Fibrillation: Insights From the ARISTOTLE Trial

Study Questions:

Does apixaban provide adequate protection from thromboembolic events in patients undergoing cardioversion of atrial fibrillation (AF)?